Global Long-acting Drug Combination Development (GLAD) Project: Preferred User Characteristics Evaluation
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 650
- 试验地点
- 1
- 主要终点
- The study will identify and characterize preferred user characteristics influencing acceptability and feasibility of potential targeted long-acting injectable ART regimens for children, adolescents and adults living with HIV in India
研究概览
简要总结
| Study Title |
Global Long-acting Drug Combination Development (GLAD) Project: Preferred User Characteristics Evaluation
|Study Design
Qualitative and quantitative assessment of factors influencing product preferences and use trajectories
|Primary Objective
To identify and characterize preferred user characteristics influencing acceptability and feasibility of potential targeted long-acting injectable ART regimens for children, adolescents and adults living with HIV in India
|Secondary Objective(s)
NA
|Research Intervention(s)/Interactions
Focus group discussions; surveys
|Study Population
People living with HIV
Healthcare providers of HIV services to people living with HIV
|Sample Size
Focus Group Discussions: n=150 participants (15 focus groups)
Surveys: n=500 participants
|Study Duration for individual participants
Focus Group Discussions: ~3 hours
Surveys: ~1 hour
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •Added in the summary section.
排除标准
- •Any individual who meets the following criteria will be excluded from participation in this study: •Conditions that would place the individual at increased risk or preclude the individual’s full compliance with or completion of the study such as advanced HIV disease or other medical condition that impairs cognition.
结局指标
主要结局
The study will identify and characterize preferred user characteristics influencing acceptability and feasibility of potential targeted long-acting injectable ART regimens for children, adolescents and adults living with HIV in India
时间窗: Baseline
次要结局
未报告次要终点